DENVER, CO--(Marketwired - Jun 14, 2016) - American Cannabis Company, Inc. (
The Satchel™ is a pouch-like case designed as a high-quality, child-resistant exit package solution for the regulated cannabis industry. The Satchel™ meets the child-safety requirements of the Consumer Products Safety Commission (CPSC), making it compliant in all states. The Satchel™ was also tested and meets the standards set by the American Society for Testing and Supplies (ASTM).
Cannabis Business Executive, a media company serving the Marijuana Industry, named its 2016 list of Top 100 Ancillary Businesses in the cannabis industry on June 7. American Cannabis Company ranked #42 from a list ranking public and private companies. The ranking was based on employee counts and revenue reported.
Corey Hollister, president and CEO of American Cannabis Company, commented: "Protection of intellectual property is a critical component of staying competitive in the rapidly developing Cannabis space as it continues to experience accelerated innovation. The success of the Satchel™ patent is an important advancement in this component of our corporate strategy. Furthermore, it is exciting to be recognized by Cannabis Business Executive as a leading Ancillary business in the rapidly growing cannabis sector."
About American Cannabis Company, Inc.:
American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis industry. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. Through our two vertically integrated businesses, American Cannabis Consulting and American Cultivator Company, a group purchasing organization, we support our clients from concept to creation to commercialization to on-going operations.
For more information, please visit: www.americancannabiscompanyinc.com.
Forward Looking Statements
This news release contains "forward-looking statements" which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "expect", "project", "plan", or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.